ATE322268T1 - Zusammensetzungen enthaltend einen alpha-2- adrenorezeptoragonisten und eine fettsaeure - Google Patents

Zusammensetzungen enthaltend einen alpha-2- adrenorezeptoragonisten und eine fettsaeure

Info

Publication number
ATE322268T1
ATE322268T1 AT02728820T AT02728820T ATE322268T1 AT E322268 T1 ATE322268 T1 AT E322268T1 AT 02728820 T AT02728820 T AT 02728820T AT 02728820 T AT02728820 T AT 02728820T AT E322268 T1 ATE322268 T1 AT E322268T1
Authority
AT
Austria
Prior art keywords
alpha
fatty acid
compositions containing
adrenoreceptor agonist
adrenoreceptor
Prior art date
Application number
AT02728820T
Other languages
English (en)
Inventor
David F Woodward
Gyorgy Ambrus
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ATE322268T1 publication Critical patent/ATE322268T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT02728820T 2001-05-03 2002-04-17 Zusammensetzungen enthaltend einen alpha-2- adrenorezeptoragonisten und eine fettsaeure ATE322268T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/848,249 US20020198210A1 (en) 2001-05-03 2001-05-03 Alpha-2-adrenergic agonist/fatty acid compositions

Publications (1)

Publication Number Publication Date
ATE322268T1 true ATE322268T1 (de) 2006-04-15

Family

ID=25302786

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02728820T ATE322268T1 (de) 2001-05-03 2002-04-17 Zusammensetzungen enthaltend einen alpha-2- adrenorezeptoragonisten und eine fettsaeure

Country Status (10)

Country Link
US (2) US20020198210A1 (de)
EP (1) EP1392308B1 (de)
JP (1) JP2004528362A (de)
AR (1) AR033312A1 (de)
AT (1) ATE322268T1 (de)
CA (1) CA2446234A1 (de)
DE (1) DE60210446T2 (de)
ES (1) ES2260429T3 (de)
TW (1) TWI223594B (de)
WO (1) WO2002089804A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7462619B2 (en) * 1999-08-31 2008-12-09 Merck & Co., Inc. Pyridazine, pyrimidine and pyrazine ethyne compounds
AU2011250793B2 (en) * 2000-07-14 2012-11-29 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
US8858961B2 (en) 2000-07-14 2014-10-14 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
US20050026924A1 (en) * 2000-07-14 2005-02-03 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
US20020198209A1 (en) 2001-05-03 2002-12-26 Allergan Sales Inc. Compositions having enhanced pharmacokinetic characteristics
AU2002256471B2 (en) * 2001-05-03 2007-05-24 Allergan, Inc. Compositions having enhanced pharmacokinetic characteristics
ATE444732T1 (de) 2003-08-07 2009-10-15 Allergan Inc Zusammensetzungen zur abgabe von therapeutika in die augen und verfahren zu ihrer herstellung und verwendung
US7842714B2 (en) * 2008-03-03 2010-11-30 Allergan, Inc. Ketorolac tromethamine compositions for treating ocular pain
US9192571B2 (en) * 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
JP2013542991A (ja) * 2010-11-16 2013-11-28 アラーガン インコーポレイテッド （３−（１−（１ｈ−イミダゾール−４−イル）エチル）−２−メチルフェニル）メタノールを含む医薬組成物
US9095576B2 (en) 2011-11-21 2015-08-04 Allergan, Inc. Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases
MX2021001645A (es) * 2018-08-29 2021-05-12 Cellix Bio Private Ltd Metodos y composiciones oftalmicas para el tratamiento de trastornos del ojo y enfermedades de la piel.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188393A (en) * 1977-04-22 1980-02-12 Sandoz Ltd. Treating spastic conditions or relaxing muscles
US4629621A (en) * 1984-07-23 1986-12-16 Zetachron, Inc. Erodible matrix for sustained release bioactive composition
DE3729299A1 (de) * 1987-09-02 1989-03-23 Beiersdorf Ag Transdermales therapeutisches system
US5021416A (en) * 1989-10-31 1991-06-04 Allergan, Inc. Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure
DE69311361T2 (de) * 1992-10-13 1998-01-08 Alcon Lab Inc Zusammensetzungen zur behandlung von glaukoma die prostaglandine und clonidinderivate enthalten
JP3607062B2 (ja) * 1997-10-24 2005-01-05 株式会社コーセー 脂肪蓄積抑制剤及びそれを含有する皮膚外用剤
WO2000044355A1 (en) * 1999-01-29 2000-08-03 Eli Lilly And Company Moxonidine salts

Also Published As

Publication number Publication date
WO2002089804A1 (en) 2002-11-14
TWI223594B (en) 2004-11-11
ES2260429T3 (es) 2006-11-01
EP1392308A1 (de) 2004-03-03
DE60210446D1 (de) 2006-05-18
US20020198210A1 (en) 2002-12-26
AR033312A1 (es) 2003-12-10
EP1392308B1 (de) 2006-04-05
US20030045524A1 (en) 2003-03-06
CA2446234A1 (en) 2002-11-14
DE60210446T2 (de) 2006-11-16
JP2004528362A (ja) 2004-09-16

Similar Documents

Publication Publication Date Title
IL173726A (en) Pharmaceutical compositions containing n-n-dihaloamino acids and their uses
NO20031744L (no) Nye ikke-imadazolforbindelser og farmasöytisk preparat omfattende slike
NO20020090D0 (no) Farmasöytiske og n¶ringsformuleringer inneholdende essensielle fettsyrer og homocystein-senkende midler
DK1480615T3 (da) Superfin formoterolformulering
DE60134851D1 (de) Härtbare zusammensetzungen und kompatibilitätsmittel
ATE392863T1 (de) Streifen zur abgabe eines mundpflegewirkstoffes
DE60333495D1 (de) Wund- und hautpflegezusammensetzungen
HK1076742A1 (en) Orodispersible pharmaceutical composition comprising agomelatine
FR2867962B1 (fr) Plaque d'osteosynthese et spherique
DE60310912D1 (de) Waschmittelzusammensetzungen und komponenten davon
DE60232963D1 (de) Oral anzuwendende zuckerkrankheitshemmende "einmal täglich" arzneizusammensetzung enthaltend eine biguanidverbindung und zumindestens einen anderen wirkstoff
DK1425019T3 (da) Farmaceutisk sammensætning omfattende et androgen
ATE322268T1 (de) Zusammensetzungen enthaltend einen alpha-2- adrenorezeptoragonisten und eine fettsaeure
DE60322720D1 (de) Feste formulierungen enthaltend eine indolinon verbindung
DE60232673D1 (de) Zusammensetzungen, die combretastatin und krebsbekämpfendes mittel enthalten
DE60332885D1 (de) Haarwaschmittel enthaltend Hydroxymonocarbonsäuren
DE60232649D1 (de) Haarpflegezusammensetzungen
ATE489069T1 (de) Mundpflegezusammensetzungen und -verfahren
ITMI20011022A0 (it) Composizioni farmaceutiche e cosmetiche contro l'invecchiamento cutaneo
ATE450255T1 (de) Nsaid-formulierung enthaltend eine granulöse zusammensetzung und eine extragranulöse zusammensetzung
DE60115997D1 (de) 1,1- and 1,2-Disubstituierte Cyclopropane, Verfahren zu deren Herstellung und deren pharmazeutischen Zusammensetzungen
DK1372728T3 (da) Sammensætning omfattende en olie-i-vand-emulsion indeholdende konjugeret linolensyre
FR2849379B1 (fr) Encapsulation d'actifs liposolubles
FR2836153B1 (fr) Tensioactif a base d'acide amine et composition cosmetique l'utilisant
ITTO20030284A1 (it) Procedimento per la realizzazione di dispositivi optoelettronici incapsulati e dispositivo incapsulato cosi' ottenuto.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties